Exicure Co-Founder Chad Mirkin Wins Kabiller Prize in Nanoscience and Nanomedicine
CHICAGO & CAMBRIDGE, Mass.–(BUSINESS WIRE)–#DigitalDrugDesign–Exicure, Inc. (OTCQB: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid…